| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 4.04e-10 | 37 | 95 | 7 | GO:0016891 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 9.90e-10 | 11 | 95 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.03e-09 | 46 | 95 | 7 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 4.24e-09 | 14 | 95 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 4.20e-08 | 21 | 95 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 9.67e-08 | 79 | 95 | 7 | GO:0004521 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.78e-07 | 136 | 95 | 8 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.78e-07 | 136 | 95 | 8 | GO:0004519 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 8.47e-07 | 37 | 95 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 9.72e-07 | 38 | 95 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 9.72e-07 | 38 | 95 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | nuclease activity | ERVK-6 RPP38 ERVK-7 ERVK-10 DICER1 N4BP2 ERVK-8 PARN ERVK-11 | 1.57e-06 | 231 | 95 | 9 | GO:0004518 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 4.42e-06 | 262 | 95 | 9 | GO:0140097 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 8.14e-06 | 152 | 95 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 2.22e-05 | 12 | 95 | 3 | GO:0070410 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ERVK-6 MYH3 MYH8 PPP1R12A RPP38 ERVK-7 ERVK-10 PDE10A DICER1 PTPRJ N4BP2 ERVK-8 PARN ERVK-11 | 2.71e-05 | 807 | 95 | 14 | GO:0016788 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 TTF2 RPP38 CHD1 ERVK-7 ERVK-10 DICER1 DDX27 N4BP2 ERVK-8 PARN ERVK-11 | 5.51e-05 | 645 | 95 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | denatured protein binding | 6.70e-05 | 3 | 95 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | I-SMAD binding | 6.76e-05 | 17 | 95 | 3 | GO:0070411 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | ERVK-6 RPP38 ERVK-7 ERVK-10 DICER1 DDX27 ERVK-8 PARN ERVK-11 | 1.67e-04 | 417 | 95 | 9 | GO:0140098 |
| GeneOntologyMolecularFunction | death receptor agonist activity | 2.22e-04 | 5 | 95 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | R-SMAD binding | 2.51e-04 | 26 | 95 | 3 | GO:0070412 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 3.32e-04 | 6 | 95 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 3.32e-04 | 6 | 95 | 2 | GO:0055131 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor binding | 4.26e-04 | 31 | 95 | 3 | GO:0005160 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERVK-6 NMNAT1 PARP3 ERVK-7 ERVK-10 AURKA N4BP2 AK5 ERVK-8 ERVK-11 ULK2 PLK4 MUSK | 4.90e-04 | 938 | 95 | 13 | GO:0016772 |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 6.65e-04 | 36 | 95 | 3 | GO:0140416 | |
| GeneOntologyMolecularFunction | SMAD binding | 7.58e-04 | 86 | 95 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 8.42e-04 | 39 | 95 | 3 | GO:0097718 | |
| GeneOntologyMolecularFunction | cAMP response element binding | 1.43e-03 | 12 | 95 | 2 | GO:0035497 | |
| GeneOntologyMolecularFunction | actin binding | 2.03e-03 | 479 | 95 | 8 | GO:0003779 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 2.08e-03 | 113 | 95 | 4 | GO:0019208 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 2.17e-03 | 54 | 95 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 2.26e-03 | 15 | 95 | 2 | GO:0140776 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 2.60e-03 | 614 | 95 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | protein kinase binding | ATF7 PPP1R12A SPG11 TRIM21 ATF2 AURKA CD4 PTPRJ PARN MUSK SMAD3 | 2.87e-03 | 873 | 95 | 11 | GO:0019901 |
| GeneOntologyMolecularFunction | misfolded protein binding | 3.26e-03 | 18 | 95 | 2 | GO:0051787 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 TTF2 TRIM4 TRIM21 ERVK-7 ERVK-10 TRIM29 CD4 ERVK-8 ERVK-11 SMAD3 | 3.36e-03 | 891 | 95 | 11 | GO:0008270 |
| GeneOntologyMolecularFunction | clathrin binding | 3.37e-03 | 63 | 95 | 3 | GO:0030276 | |
| GeneOntologyMolecularFunction | death receptor activity | 4.43e-03 | 21 | 95 | 2 | GO:0005035 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 5.10e-03 | 441 | 95 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | cadherin binding | 5.62e-03 | 339 | 95 | 6 | GO:0045296 | |
| GeneOntologyBiologicalProcess | DNA integration | 2.33e-09 | 13 | 95 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 8.54e-08 | 48 | 95 | 6 | GO:0000731 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 2.31e-06 | 83 | 95 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 7.56e-06 | 218 | 95 | 8 | GO:0071897 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | ERVK-6 TTF2 NMNAT1 SWAP70 PARP3 ERVK-7 ERVK-10 DICER1 KMT5B N4BP2 SYCP1 ERVK-8 PARN ERVK-11 HSPA1A HSPA1B TADA3 | 7.99e-06 | 1081 | 95 | 17 | GO:0006259 |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 CHD1 TRIM21 ERVK-7 ERVK-10 DICER1 HEXIM1 CD4 ERVK-8 HSPA1A HSPA1B | 9.46e-06 | 464 | 95 | 11 | GO:0016032 |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 TTF2 PARP3 ERVK-7 ERVK-10 KMT5B SYCP1 ERVK-8 ERVK-11 HSPA1A HSPA1B TADA3 | 4.22e-05 | 648 | 95 | 12 | GO:0006281 |
| GeneOntologyBiologicalProcess | regulation of mitotic spindle organization | 4.98e-05 | 44 | 95 | 4 | GO:0060236 | |
| GeneOntologyBiologicalProcess | DNA recombination | ERVK-6 SWAP70 PARP3 ERVK-7 ERVK-10 KMT5B SYCP1 ERVK-8 ERVK-11 | 5.06e-05 | 368 | 95 | 9 | GO:0006310 |
| GeneOntologyBiologicalProcess | organelle assembly | MAP9 MYH3 ERICH3 SMURF1 SPG11 DICER1 SEPTIN6 AURKA SYNE2 SSX2IP SCLT1 HSPA1A HSPA1B DNAH8 ULK2 PLK4 | 5.94e-05 | 1138 | 95 | 16 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of spindle organization | 7.04e-05 | 48 | 95 | 4 | GO:0090224 | |
| GeneOntologyBiologicalProcess | microtubule-based process | MAP9 PPP1R12A KTN1 PARP3 SPG11 QRICH2 DICER1 AURKA DST SYNE2 SSX2IP HSPA1A HSPA1B DNAH8 PLK4 | 9.47e-05 | 1058 | 95 | 15 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP9 PPP1R12A PARP3 DICER1 AURKA DST SYNE2 SSX2IP HSPA1A HSPA1B DNAH8 PLK4 | 1.15e-04 | 720 | 95 | 12 | GO:0000226 |
| GeneOntologyBiologicalProcess | DNA damage response | ERVK-6 TTF2 PARP3 ERVK-7 ERVK-10 ATF2 KMT5B SYCP1 ERVK-8 ZBTB40 ERVK-11 HSPA1A HSPA1B TADA3 | 1.22e-04 | 959 | 95 | 14 | GO:0006974 |
| GeneOntologyBiologicalProcess | motor neuron apoptotic process | 2.85e-04 | 28 | 95 | 3 | GO:0097049 | |
| GeneOntologyBiologicalProcess | cellular heat acclimation | 3.11e-04 | 6 | 95 | 2 | GO:0070370 | |
| GeneOntologyCellularComponent | centrosome | PPP1R12A PARP3 TTC23L CCDC141 AURKA CCDC112 AK5 KIAA1217 SSX2IP SCLT1 HSPA1A HSPA1B PLK4 | 3.99e-05 | 770 | 94 | 13 | GO:0005813 |
| GeneOntologyCellularComponent | centriole | 1.27e-04 | 172 | 94 | 6 | GO:0005814 | |
| GeneOntologyCellularComponent | microtubule organizing center | PPP1R12A PARP3 TTC23L CCDC141 AURKA CCDC112 AK5 KIAA1217 SSX2IP SCLT1 HSPA1A HSPA1B PLK4 | 2.34e-04 | 919 | 94 | 13 | GO:0005815 |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 5.50e-04 | 8 | 94 | 2 | GO:0071144 | |
| Domain | TF_CRE-BP1-typ | 6.56e-05 | 3 | 88 | 2 | IPR016378 | |
| Domain | PP2A_PR55 | 1.31e-04 | 4 | 88 | 2 | IPR000009 | |
| Domain | PP2A_PR55_CS | 1.31e-04 | 4 | 88 | 2 | IPR018067 | |
| Domain | PR55_2 | 1.31e-04 | 4 | 88 | 2 | PS01025 | |
| Domain | PR55_1 | 1.31e-04 | 4 | 88 | 2 | PS01024 | |
| Domain | Spectrin | 1.67e-04 | 23 | 88 | 3 | PF00435 | |
| Domain | Spectrin_repeat | 3.38e-04 | 29 | 88 | 3 | IPR002017 | |
| Domain | Dwarfin | 6.03e-04 | 8 | 88 | 2 | IPR013790 | |
| Domain | DWB | 6.03e-04 | 8 | 88 | 2 | SM00524 | |
| Domain | MH2 | 6.03e-04 | 8 | 88 | 2 | PS51076 | |
| Domain | MH1 | 6.03e-04 | 8 | 88 | 2 | PS51075 | |
| Domain | - | 6.03e-04 | 8 | 88 | 2 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 6.03e-04 | 8 | 88 | 2 | IPR013019 | |
| Domain | MH2 | 6.03e-04 | 8 | 88 | 2 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 6.03e-04 | 8 | 88 | 2 | IPR001132 | |
| Domain | MYTH4 | 7.73e-04 | 9 | 88 | 2 | PS51016 | |
| Domain | MyTH4_dom | 7.73e-04 | 9 | 88 | 2 | IPR000857 | |
| Domain | MyTH4 | 7.73e-04 | 9 | 88 | 2 | PF00784 | |
| Domain | MyTH4 | 7.73e-04 | 9 | 88 | 2 | SM00139 | |
| Domain | FERM_M | 1.33e-03 | 46 | 88 | 3 | PF00373 | |
| Domain | MAD_homology1_Dwarfin-type | 1.40e-03 | 12 | 88 | 2 | IPR003619 | |
| Domain | DWA | 1.40e-03 | 12 | 88 | 2 | SM00523 | |
| Domain | MH1 | 1.40e-03 | 12 | 88 | 2 | PF03165 | |
| Domain | - | 1.59e-03 | 49 | 88 | 3 | 1.20.80.10 | |
| Domain | FERM_central | 1.59e-03 | 49 | 88 | 3 | IPR019748 | |
| Domain | FERM_domain | 1.59e-03 | 49 | 88 | 3 | IPR000299 | |
| Domain | Helicase_C | 1.64e-03 | 107 | 88 | 4 | PF00271 | |
| Domain | HELICc | 1.64e-03 | 107 | 88 | 4 | SM00490 | |
| Domain | FERM_1 | 1.69e-03 | 50 | 88 | 3 | PS00660 | |
| Domain | FERM_2 | 1.69e-03 | 50 | 88 | 3 | PS00661 | |
| Domain | FERM_3 | 1.69e-03 | 50 | 88 | 3 | PS50057 | |
| Domain | Band_41_domain | 1.69e-03 | 50 | 88 | 3 | IPR019749 | |
| Domain | B41 | 1.69e-03 | 50 | 88 | 3 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 1.69e-03 | 50 | 88 | 3 | IPR014352 | |
| Domain | Helicase_C | 1.70e-03 | 108 | 88 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 1.76e-03 | 109 | 88 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.76e-03 | 109 | 88 | 4 | PS51192 | |
| Domain | DEXDc | 1.76e-03 | 109 | 88 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.82e-03 | 110 | 88 | 4 | IPR014001 | |
| Domain | Myosin_N | 2.21e-03 | 15 | 88 | 2 | PF02736 | |
| Domain | Myosin_N | 2.21e-03 | 15 | 88 | 2 | IPR004009 | |
| Domain | HSP70 | 2.52e-03 | 16 | 88 | 2 | PF00012 | |
| Domain | SMAD_dom-like | 2.52e-03 | 16 | 88 | 2 | IPR017855 | |
| Domain | - | 2.52e-03 | 16 | 88 | 2 | 2.60.200.10 | |
| Domain | HSP70_2 | 2.85e-03 | 17 | 88 | 2 | PS00329 | |
| Domain | HSP70_3 | 2.85e-03 | 17 | 88 | 2 | PS01036 | |
| Domain | HSP70_1 | 2.85e-03 | 17 | 88 | 2 | PS00297 | |
| Domain | Myosin_tail_1 | 3.20e-03 | 18 | 88 | 2 | PF01576 | |
| Domain | Myosin_tail | 3.20e-03 | 18 | 88 | 2 | IPR002928 | |
| Domain | Hsp_70_fam | 3.20e-03 | 18 | 88 | 2 | IPR013126 | |
| Domain | Myosin-like_IQ_dom | 3.56e-03 | 19 | 88 | 2 | IPR027401 | |
| Domain | - | 3.56e-03 | 19 | 88 | 2 | 4.10.270.10 | |
| Domain | BBOX | 4.23e-03 | 69 | 88 | 3 | SM00336 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 4.23e-03 | 69 | 88 | 3 | IPR020636 | |
| Domain | - | 4.59e-03 | 71 | 88 | 3 | 4.10.45.10 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 2.47e-04 | 26 | 67 | 3 | MM14878 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 2.47e-04 | 26 | 67 | 3 | M628 | |
| Pathway | REACTOME_SIGNALING_BY_NODAL | 3.30e-04 | 6 | 67 | 2 | MM14517 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 3.96e-04 | 73 | 67 | 4 | M638 | |
| Pathway | KEGG_TIGHT_JUNCTION | 4.05e-04 | 132 | 67 | 5 | M11355 | |
| Pathway | REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER | 4.60e-04 | 7 | 67 | 2 | M29623 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 4.60e-04 | 7 | 67 | 2 | MM15661 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 4.86e-04 | 77 | 67 | 4 | MM14670 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY | 6.12e-04 | 8 | 67 | 2 | M47415 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY | 6.12e-04 | 8 | 67 | 2 | M47849 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY | 6.12e-04 | 8 | 67 | 2 | M47846 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER | 6.12e-04 | 8 | 67 | 2 | M27246 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 6.17e-04 | 82 | 67 | 4 | M2 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 6.55e-04 | 36 | 67 | 3 | M633 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 7.39e-04 | 86 | 67 | 4 | M2642 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH3 MYH8 CALD1 PPP2R2D PPP1R12A CHD1 DICER1 HEXIM1 AURKA CD4 DST PARN HSPA1A HSPA1B PLK4 | 3.00e-08 | 910 | 96 | 15 | 36736316 |
| Pubmed | MAP9 MYH3 MYH8 CALD1 FAM133A PPP1R12A KTN1 ANKRD30B SPG11 PDE10A TFAM DST N4BP2 SYNE2 SYCP1 ANKRD30A DNAH8 CCDC191 | 7.47e-08 | 1442 | 96 | 18 | 35575683 | |
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 30280598 | ||
| Pubmed | Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation. | 8.14e-08 | 4 | 96 | 3 | 20207742 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 8.14e-08 | 4 | 96 | 3 | 10469592 | |
| Pubmed | BDP1 ATF7 MYH3 STARD4 NMNAT1 COX4I1 RPP38 TRIM21 E2F5 DICER1 AURKA PPP2R2B DST VPS35L SERTAD4 ANKRD30A PLK4 | 8.68e-08 | 1293 | 96 | 17 | 15342556 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.03e-07 | 5 | 96 | 3 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 2.53e-07 | 94 | 96 | 6 | 21542922 | |
| Pubmed | 4.05e-07 | 6 | 96 | 3 | 23781096 | ||
| Pubmed | CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. | 7.08e-07 | 7 | 96 | 3 | 14701756 | |
| Pubmed | 7.08e-07 | 7 | 96 | 3 | 38383842 | ||
| Pubmed | E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. | 7.08e-07 | 7 | 96 | 3 | 12150994 | |
| Pubmed | 7.08e-07 | 7 | 96 | 3 | 12370310 | ||
| Pubmed | 9.70e-07 | 118 | 96 | 6 | 30979931 | ||
| Pubmed | 1.13e-06 | 8 | 96 | 3 | 28881580 | ||
| Pubmed | 1.22e-06 | 497 | 96 | 10 | 23414517 | ||
| Pubmed | 1.23e-06 | 29 | 96 | 4 | 32520726 | ||
| Pubmed | 1.69e-06 | 9 | 96 | 3 | 10708948 | ||
| Pubmed | 2.41e-06 | 10 | 96 | 3 | 15221015 | ||
| Pubmed | 2.77e-06 | 79 | 96 | 5 | 25921334 | ||
| Pubmed | 3.31e-06 | 11 | 96 | 3 | 11988168 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ATF7 TTF2 PPP2R2D PPP1R12A KTN1 TRIM29 ATF2 PHF21A CBFA2T2 ZBTB40 SMAD2 SMAD3 | 4.36e-06 | 857 | 96 | 12 | 25609649 |
| Pubmed | Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. | 4.40e-06 | 12 | 96 | 3 | 19917253 | |
| Pubmed | 4.71e-06 | 88 | 96 | 5 | 25144556 | ||
| Pubmed | Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. | 5.71e-06 | 13 | 96 | 3 | 19914168 | |
| Pubmed | 7.32e-06 | 360 | 96 | 8 | 33111431 | ||
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 7.54e-06 | 2 | 96 | 2 | 12411538 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 2868009 | ||
| Pubmed | Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients. | 7.54e-06 | 2 | 96 | 2 | 24328534 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 36050359 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 11984875 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 3786141 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 23666711 | ||
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 7.54e-06 | 2 | 96 | 2 | 26923070 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 18210139 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 16482515 | ||
| Pubmed | Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. | 7.54e-06 | 2 | 96 | 2 | 11864979 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 17925329 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 20010874 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 15719414 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 26976620 | ||
| Pubmed | Inhibition of MuSK expression by CREB interacting with a CRE-like element and MyoD. | 7.54e-06 | 2 | 96 | 2 | 15964791 | |
| Pubmed | Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. | 7.54e-06 | 2 | 96 | 2 | 16382155 | |
| Pubmed | Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. | 7.54e-06 | 2 | 96 | 2 | 21187371 | |
| Pubmed | Plk4 and Aurora A cooperate in the initiation of acentriolar spindle assembly in mammalian oocytes. | 7.54e-06 | 2 | 96 | 2 | 28972102 | |
| Pubmed | Inducible expression of an hsp68-lacZ hybrid gene in transgenic mice. | 7.54e-06 | 2 | 96 | 2 | 2557196 | |
| Pubmed | Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. | 7.54e-06 | 2 | 96 | 2 | 20430459 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 20235222 | ||
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 7.54e-06 | 2 | 96 | 2 | 20876613 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 20223214 | ||
| Pubmed | Evidence for a role of Smad3 and Smad2 in stabilization of the tumor-derived mutant Smad2.Q407R. | 7.54e-06 | 2 | 96 | 2 | 12700238 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 33245228 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 7.54e-06 | 2 | 96 | 2 | 23704948 | |
| Pubmed | Formation of the definitive endoderm in mouse is a Smad2-dependent process. | 7.54e-06 | 2 | 96 | 2 | 10862745 | |
| Pubmed | Smad2-dependent downregulation of miR-30 is required for TGF-β-induced apoptosis in podocytes. | 7.54e-06 | 2 | 96 | 2 | 24086574 | |
| Pubmed | Structure and expression of the human gene encoding major heat shock protein HSP70. | 7.54e-06 | 2 | 96 | 2 | 2858050 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 17513788 | ||
| Pubmed | IL-6 activates HSP72 gene expression in human skeletal muscle. | 7.54e-06 | 2 | 96 | 2 | 12207910 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 28837204 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 29572464 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 15988927 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 32705438 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 28099259 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 26354774 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 26448330 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 12714332 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 19299581 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 11713291 | ||
| Pubmed | Heat shock protein 72 (Hsp72) improves long term recovery after focal cerebral ischemia in mice. | 7.54e-06 | 2 | 96 | 2 | 21108992 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 35780861 | ||
| Pubmed | Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70). | 7.54e-06 | 2 | 96 | 2 | 31320473 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 29174331 | ||
| Pubmed | Differential expression of AURKA/PLK4 in quiescence and senescence of osteosarcoma U2OS cells. | 7.54e-06 | 2 | 96 | 2 | 32200684 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 16971451 | ||
| Pubmed | SMAD2/3 Phosphorylation Is Downregulated in T Cells in HIV-Infected Patients. | 7.54e-06 | 2 | 96 | 2 | 36226468 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 25185661 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 22228025 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 29631603 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 21757701 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 17192514 | ||
| Pubmed | Role of membrane Hsp70 in radiation sensitivity of tumor cells. | 7.54e-06 | 2 | 96 | 2 | 26197988 | |
| Pubmed | Hsp72 overexpression accelerates the recovery from caerulein-induced pancreatitis. | 7.54e-06 | 2 | 96 | 2 | 22792201 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 28557134 | ||
| Pubmed | ATF2 and ATF7 Are Critical Mediators of Intestinal Epithelial Repair. | 7.54e-06 | 2 | 96 | 2 | 31958521 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 9820195 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 26992562 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 15972691 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 19157555 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 37298493 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 21732483 | ||
| Pubmed | Smad2 and 3 transcription factors control muscle mass in adulthood. | 7.54e-06 | 2 | 96 | 2 | 19357234 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 26905010 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 25618331 | ||
| Pubmed | Cigarette smoke exacerbates mouse allergic asthma through Smad proteins expressed in mast cells. | 7.54e-06 | 2 | 96 | 2 | 21496353 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 33769459 | ||
| Pubmed | Extracellular heat shock protein 72 is a marker of the stress protein response in acute lung injury. | 7.54e-06 | 2 | 96 | 2 | 16679378 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 19639652 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 15665291 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 16100242 | ||
| Interaction | ANKRD30A interactions | 5.07e-06 | 8 | 92 | 3 | int:ANKRD30A | |
| Interaction | NPM1 interactions | BDP1 NMNAT1 SWAP70 PPP1R12A KTN1 RPP38 CHD1 TRIM21 DICER1 DDX27 HEXIM1 AURKA CD4 SYNE2 SYCP1 ANKRD30A HSPA1A HSPA1B | 6.91e-06 | 1201 | 92 | 18 | int:NPM1 |
| Interaction | CTNNB1 interactions | COX4I1 PPP1R12A SMURF1 TRIM21 ATF2 TFAM AURKA DST PTPRJ KIAA1217 SYNE2 HSPA1A HSPA1B TADA3 SMAD2 SMAD3 | 1.21e-05 | 1009 | 92 | 16 | int:CTNNB1 |
| Interaction | RAB11A interactions | CALD1 SWAP70 KTN1 TRIM29 ATF2 TFAM DDX27 HEXIM1 COLEC12 DST PTPRJ SYNE2 HSPA1A EPB41 | 2.30e-05 | 830 | 92 | 14 | int:RAB11A |
| Interaction | FHL1 interactions | 2.78e-05 | 129 | 92 | 6 | int:FHL1 | |
| Interaction | TRIB2 interactions | 6.24e-05 | 47 | 92 | 4 | int:TRIB2 | |
| Interaction | SREBF2 interactions | 6.45e-05 | 297 | 92 | 8 | int:SREBF2 | |
| Interaction | ATF3 interactions | 7.08e-05 | 94 | 92 | 5 | int:ATF3 | |
| Interaction | TOMM70 interactions | 7.23e-05 | 153 | 92 | 6 | int:TOMM70 | |
| Interaction | FAM107B interactions | 8.46e-05 | 19 | 92 | 3 | int:FAM107B | |
| Interaction | SERTAD4 interactions | 8.46e-05 | 19 | 92 | 3 | int:SERTAD4 | |
| Interaction | KDM1A interactions | TRIM4 PPP1R12A RUSC1 TRIM21 SEPTIN6 PHF21A DST N4BP2 KIAA1217 SSX2IP SCLT1 HSPA1A HSPA1B TADA3 | 8.97e-05 | 941 | 92 | 14 | int:KDM1A |
| Interaction | DCTN1 interactions | TTF2 MAP9 SMURF1 TRIM29 HEXIM1 AURKA DST KIAA1217 HSPA1A EPB41 | 8.98e-05 | 497 | 92 | 10 | int:DCTN1 |
| Interaction | C1orf116 interactions | 9.92e-05 | 20 | 92 | 3 | int:C1orf116 | |
| GeneFamily | SMAD family | 2.89e-04 | 8 | 59 | 2 | 750 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 5.80e-04 | 50 | 59 | 3 | 1293 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 1.07e-03 | 15 | 59 | 2 | 696 | |
| GeneFamily | Myosin heavy chains | 1.07e-03 | 15 | 59 | 2 | 1098 | |
| GeneFamily | Heat shock 70kDa proteins | 1.38e-03 | 17 | 59 | 2 | 583 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 3.69e-03 | 95 | 59 | 3 | 59 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 9.38e-07 | 300 | 90 | 9 | M8702 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SWAP70 PPP1R12A CHD1 SPG11 E2F5 ATF2 DICER1 PHF21A AURKA DST SYNE2 PARN SMAD3 | 7.08e-06 | 856 | 90 | 13 | M4500 |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP | 1.44e-05 | 152 | 90 | 6 | M2964 | |
| Coexpression | HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN | 2.73e-05 | 102 | 90 | 5 | M2124 | |
| Coexpression | LAMB_CCND1_TARGETS | 4.28e-05 | 20 | 90 | 3 | M2935 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 5.65e-05 | 194 | 90 | 6 | M7467 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN | 6.69e-05 | 200 | 90 | 6 | M4979 | |
| Coexpression | GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP | 6.69e-05 | 200 | 90 | 6 | M7489 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 TTF2 KTN1 RPP38 CHD1 PDE10A RBM25 N4BP2 SCLT1 PLK4 EPB41 | 1.23e-05 | 532 | 88 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#5 | 3.26e-05 | 88 | 88 | 5 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_500_K5 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.42e-09 | 196 | 90 | 8 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 6.68e-09 | 197 | 90 | 8 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.58e-07 | 198 | 90 | 7 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | COVID-19-T_cells-Tregs|COVID-19 / group, cell type (main and fine annotations) | 1.84e-06 | 181 | 90 | 6 | 534659cf754326c6a73c0daa30e9d610612a0292 | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.99e-06 | 197 | 90 | 6 | de5448fcdf4e433fc167496413abe5d0c8a5c6d8 | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.17e-06 | 199 | 90 | 6 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.27e-06 | 200 | 90 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.27e-06 | 200 | 90 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.27e-06 | 200 | 90 | 6 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-05 | 153 | 90 | 5 | 7480522a47e367f8facc4f5d599fbaf0b5ad4007 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.63e-05 | 156 | 90 | 5 | 53ded973358e3e48054130131e959f0d1f4ef60f | |
| ToppCell | COVID-Treg|COVID / Condition, Cell_class and T cell subcluster | 1.63e-05 | 156 | 90 | 5 | a1dd61d4c9ed8f283f0fcbf875c5fd7807ca370d | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 164 | 90 | 5 | 950f87d9dacee45c9004a9bf894543de38f72ee5 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 164 | 90 | 5 | c33910a6d87580902e9e7bd27afe6ea63b5eff8d | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 164 | 90 | 5 | bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.33e-05 | 168 | 90 | 5 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.33e-05 | 168 | 90 | 5 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | Control-T_cells-Tregs|Control / group, cell type (main and fine annotations) | 2.39e-05 | 169 | 90 | 5 | e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.39e-05 | 169 | 90 | 5 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-05 | 170 | 90 | 5 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-05 | 170 | 90 | 5 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-05 | 170 | 90 | 5 | 52787f6d529c285d9f0c04cc022710ead5b89b3f | |
| ToppCell | mild_COVID-19-Treg|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.60e-05 | 172 | 90 | 5 | 77af6324c06b67867e7ce07706536fe38de5ed7b | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 174 | 90 | 5 | 9d5dcd46cf346c381dea68ada6665f7fb68114a3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 174 | 90 | 5 | 53cec5c666c45278a71c21dd9c62a052a97e0fdf | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 3.15e-05 | 179 | 90 | 5 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | facs-Heart-LV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 182 | 90 | 5 | 6dff753d65ba45db81f3cc0c9f59e1779d490955 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-05 | 183 | 90 | 5 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Tregs|blood / Manually curated celltypes from each tissue | 3.59e-05 | 184 | 90 | 5 | 22c15ce30171c687ab564f4383ae74d38b759272 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 185 | 90 | 5 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 185 | 90 | 5 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 186 | 90 | 5 | 8eafd4bea692f7ef33de27dd53f9d1fe67deaad8 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 186 | 90 | 5 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.88e-05 | 187 | 90 | 5 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.98e-05 | 188 | 90 | 5 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.08e-05 | 189 | 90 | 5 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.19e-05 | 190 | 90 | 5 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-regulatory_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.19e-05 | 190 | 90 | 5 | b69709323a9f1b368b5a4f87295b9f7fd9c9be8e | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 4.19e-05 | 190 | 90 | 5 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 4.29e-05 | 191 | 90 | 5 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | facs-MAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | b4fba92f9bd1354a07fedfca7304a3757e6d5beb | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 4.29e-05 | 191 | 90 | 5 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-IPC_like-IPCs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.40e-05 | 192 | 90 | 5 | bd91bf0ceeac49dc5a18aa2e401244db0ca596ae | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.40e-05 | 192 | 90 | 5 | 7a90ec9fc8f29216c4828e0cf5d040906456e53b | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-Treg|COVID-19_Severe / Disease group, lineage and cell class | 4.40e-05 | 192 | 90 | 5 | 3fb4c148dadcf5e79094e55c6bb53ec7bf9d44c8 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.40e-05 | 192 | 90 | 5 | d883b91bbab71673de4858346d3ab33e5fbbf842 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-Treg-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.40e-05 | 192 | 90 | 5 | d85a785a12076e34c404171363a647f318926b18 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-IPC_like|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.40e-05 | 192 | 90 | 5 | 18fbf485ad762ba7a9ac3e19bad136b0cf3af3c5 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.40e-05 | 192 | 90 | 5 | 230f3090607a62bb6d1e1f4b0341ee96d93f1c00 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.51e-05 | 193 | 90 | 5 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.51e-05 | 193 | 90 | 5 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.51e-05 | 193 | 90 | 5 | c3cffafc1d40c3d7cf81034d5c51f1c78f5eb0a9 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 4.62e-05 | 194 | 90 | 5 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.62e-05 | 194 | 90 | 5 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.74e-05 | 195 | 90 | 5 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.74e-05 | 195 | 90 | 5 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.74e-05 | 195 | 90 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | COVID-19-Lymphoid-Tregs|Lymphoid / Condition, Lineage and Cell class | 4.74e-05 | 195 | 90 | 5 | 9ad844d9d5aac39d133ae8ab9c4839300f08064c | |
| ToppCell | COVID-19-Lymphoid-Tregs|COVID-19 / Condition, Lineage and Cell class | 4.74e-05 | 195 | 90 | 5 | 284cfff4d59ecc1430997b118de17fee167dcbb1 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.74e-05 | 195 | 90 | 5 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.74e-05 | 195 | 90 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 196 | 90 | 5 | 2aa1acea3cefb3dbe3afdb04875c96b927e9d860 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 196 | 90 | 5 | 59ca204c96149fdff08bc524cfa832a30e60e8a4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 196 | 90 | 5 | d06a29775a41223e02728615af519a18f7e82e8b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-05 | 196 | 90 | 5 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.97e-05 | 197 | 90 | 5 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | T_cells-Treg_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.97e-05 | 197 | 90 | 5 | ec9398ae3577f61d6b1e6aba50ef4261aaaa7610 | |
| ToppCell | 3'-Broncho-tracheal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 197 | 90 | 5 | 5d33f8a6940431093e927b186fb9b630a89d8ec1 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 5.09e-05 | 198 | 90 | 5 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 5.09e-05 | 198 | 90 | 5 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | severe-Treg|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.09e-05 | 198 | 90 | 5 | 377980b9f7d02818e1d145e6884604f8bfacc4f2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.09e-05 | 198 | 90 | 5 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 5.09e-05 | 198 | 90 | 5 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | mLN-(1)_T_cell-(15)_Treg|mLN / shred on region, Cell_type, and subtype | 5.09e-05 | 198 | 90 | 5 | d4885f9c59b275e4e50dfcfb51c5351bebba1769 | |
| ToppCell | mLN-T_cell-Treg|mLN / Region, Cell class and subclass | 5.09e-05 | 198 | 90 | 5 | 6ce9681d1287632956176239f223e71abb8de44f | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.09e-05 | 198 | 90 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.09e-05 | 198 | 90 | 5 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.09e-05 | 198 | 90 | 5 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.22e-05 | 199 | 90 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.22e-05 | 199 | 90 | 5 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 5.22e-05 | 199 | 90 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 90 | 5 | afac850d5a40de0d6f02857cf81a19443d90b1eb | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-Treg|COVID-19_Severe / Disease, condition lineage and cell class | 5.34e-05 | 200 | 90 | 5 | 2b363f2a1d08019b6ff0b10419870049063cc1cf | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.34e-05 | 200 | 90 | 5 | 592c7c3ded409a9957cbcdc62fcc213fa8eae598 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.34e-05 | 200 | 90 | 5 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.34e-05 | 200 | 90 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 90 | 5 | 9da214f756a03516eaafde00289b90f69623b9f3 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.34e-05 | 200 | 90 | 5 | 8cfbde43c5e66269ad128aa5398b1517667d7d36 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.34e-05 | 200 | 90 | 5 | 4f624c3c57d1a84baa86d0830cb1b83ae110bf67 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Basal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.34e-05 | 200 | 90 | 5 | 7098ae4b0ea8ba607519eaed8577c577530fc2a1 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 90 | 5 | 0594ca7bc313b73e1dc800cf058f8f798b0284cb | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.34e-05 | 200 | 90 | 5 | 61811380d9252f12f27b7ad4752380b52692677f | |
| ToppCell | Lung_Parenchyma|World / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.47e-05 | 201 | 90 | 5 | 91ec5eebe93a3c7b1a33c27e5da949b123b676a8 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-04 | 125 | 90 | 4 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.62e-04 | 135 | 90 | 4 | b128596653a5e3b64ed7f657bbfeda35438e2e48 | |
| ToppCell | COVID-Treg-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 2.62e-04 | 153 | 90 | 4 | 47c649fd4231e507f2d4654ccac61faf21a04eff | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 7.49e-07 | 184 | 91 | 8 | 2321_DN | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 8.54e-05 | 5 | 87 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | Loeys-Dietz Syndrome | 1.79e-04 | 7 | 87 | 2 | C2697932 | |
| Disease | Distal arthrogryposis | 3.05e-04 | 9 | 87 | 2 | cv:C0265213 | |
| Disease | Major depression, single episode | 3.05e-04 | 9 | 87 | 2 | C0024517 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | level of Sphingomyelin (d34:0) in blood serum | 4.65e-04 | 11 | 87 | 2 | OBA_2045176 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 5.56e-04 | 12 | 87 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 5.56e-04 | 12 | 87 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 5.56e-04 | 12 | 87 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | Alzheimer's disease (is_implicated_in) | 6.39e-04 | 132 | 87 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 6.56e-04 | 13 | 87 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 8.80e-04 | 15 | 87 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 1.00e-03 | 16 | 87 | 2 | OBA_2045093 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.73e-03 | 80 | 87 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | Left Ventricle Remodeling | 1.74e-03 | 21 | 87 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 1.74e-03 | 21 | 87 | 2 | C0600519 | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 2.09e-03 | 23 | 87 | 2 | OBA_2045181 | |
| Disease | Carcinoma, Pancreatic Ductal | 2.27e-03 | 24 | 87 | 2 | C0887833 | |
| Disease | Lynch syndrome (is_implicated_in) | 2.27e-03 | 24 | 87 | 2 | DOID:3883 (is_implicated_in) | |
| Disease | dental caries | 2.31e-03 | 187 | 87 | 4 | EFO_0003819 | |
| Disease | complement C4b measurement | 2.47e-03 | 25 | 87 | 2 | EFO_0008092 | |
| Disease | hypertrophic cardiomyopathy | 2.57e-03 | 92 | 87 | 3 | EFO_0000538 | |
| Disease | Colorectal cancer | 2.88e-03 | 27 | 87 | 2 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 2.88e-03 | 27 | 87 | 2 | 114500 | |
| Disease | Neoplasm of the large intestine | 2.88e-03 | 27 | 87 | 2 | cv:C0009404 | |
| Disease | C-reactive protein measurement | PPP2R2D HLX SPG11 CCDC168 PDE10A PHF21A RBM25 AK5 ZBTB40 MUSK | 2.89e-03 | 1206 | 87 | 10 | EFO_0004458 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KEKDQAWKTLKERES | 411 | O75528 | |
| KSKLWEESTAQVKDK | 701 | Q5RHP9 | |
| SKTWLDSAKEIKKQV | 261 | P11171 | |
| NDKTVKLWKVSERDK | 111 | Q00005 | |
| EIKNKFKREEKTNGW | 336 | A6H8Y1 | |
| QKLAVEAWKKQKSIE | 271 | Q8NEF3 | |
| AKEIKSQLENQKAKW | 991 | Q9BXX2 | |
| SKQKNEESKKRQWAL | 116 | O14965 | |
| RLKEEWSLFKEQKKN | 431 | Q9Y2D8 | |
| DNLSSVKETQKKWAE | 186 | P30040 | |
| AKEIKSQLENQKVKW | 1006 | Q9BXX3 | |
| NDKTIKLWKISERDK | 121 | Q66LE6 | |
| QKRKVWVQSLEKKAE | 371 | P15336 | |
| QKRKLWVSSLEKKAE | 351 | P17544 | |
| SAEKRKAKWESLQNK | 1016 | Q9UPY3 | |
| SSEVKRKKHKDEDWQ | 136 | O14646 | |
| SWFQTKEERKKEKIA | 651 | Q96GQ7 | |
| VDAKTKAQLDEWKAK | 161 | P49756 | |
| TVKTLAKEVWQEKAK | 1086 | Q9H0J4 | |
| KQEEKQIKRKWTEDS | 516 | O95453 | |
| EKKFREKTKNNWAER | 126 | Q9Y6F1 | |
| FWQVSKEEKEKRDKA | 171 | Q5SW96 | |
| WRKKRKDAKNNEVSF | 996 | Q12913 | |
| WEEVKKQLENKKTGS | 41 | Q8N9E0 | |
| WKKQKDKVAELENSE | 56 | P19256 | |
| EKKKDNLTAVEKWNE | 551 | Q49MG5 | |
| WRHSKEAQAQKDKDK | 331 | Q14774 | |
| CDKVKWDTFVSQEKK | 51 | Q9Y6K8 | |
| DERDKVQKKTFTKWI | 31 | Q03001 | |
| KWVSNISKTLKDAEK | 1451 | Q03001 | |
| WKRSKKAKEQAAQEA | 296 | P50219 | |
| IQDVKRKKSQKWDES | 36 | O14990 | |
| KIVATKEWKRNDKIE | 211 | Q4FZB7 | |
| TWEEKKKFDEKQSLR | 171 | O94992 | |
| DKKKVLDKCQEVISW | 566 | P0DMV9 | |
| EFWKKTEEAVNKVKI | 436 | O43439 | |
| DKKQRNFDKVLSEWK | 1446 | P13535 | |
| ETVEKWLKRKNNKSE | 41 | Q9Y233 | |
| AKKDTDWLKEKVQSL | 251 | Q5KU26 | |
| KTWIKSKEKENDLQV | 3476 | Q96JB1 | |
| KQKLLKWSSDLKQER | 566 | Q96BD5 | |
| LKNKFDVTWKQAKDI | 606 | P63132 | |
| ENKWKVKVDESHKTI | 1161 | Q86UP2 | |
| LKNKFDVTWKQAKDI | 606 | P63135 | |
| LKNKFDVTWKQAKDI | 606 | Q9BXR3 | |
| KAAKIKEWVTVKLNE | 126 | Q8IVE3 | |
| LKNKFDVTWKQAKDI | 606 | Q9QC07 | |
| LTEFQDKQIKDWKKR | 341 | P83110 | |
| IKAKEWNSAVEKLKS | 296 | Q6ZP82 | |
| IDLIEKKSKNSIQWK | 101 | Q15329 | |
| TVKAAWKIEKKRQEE | 266 | Q8NCU4 | |
| NKEAKVSKREKAVWV | 346 | P01730 | |
| DKKKVLDKCQEVISW | 566 | P0DMV8 | |
| NKKEFKTADWKTRAD | 2736 | Q8NDH2 | |
| DILNTKKLQWKSKEQ | 5041 | Q8NDH2 | |
| SASQKALKEKEKASW | 56 | P13073 | |
| KKKKNWGADVVAESR | 16 | Q494R4 | |
| KIDTEKTKAEWKTTE | 236 | Q9BVN2 | |
| KWQKEKDRIKSFTTN | 291 | Q14134 | |
| KLEQSKKELTLWEKN | 346 | Q7Z5M5 | |
| KEKKTDAKQQVSGWT | 91 | P78345 | |
| TWDQCEKKIKELKSR | 5811 | Q8WXH0 | |
| KKENKVTWGARSKDQ | 186 | P78414 | |
| RAVSIEKAEKKWEEK | 961 | Q5T5P2 | |
| VWKVTKDKSNKNRET | 46 | A0A5F9ZH02 | |
| KQRNFDKVLAEWKTK | 1446 | P11055 | |
| NNVNESWKKSLRKKE | 326 | Q9NUC0 | |
| KLKTVKENWKNLSDS | 181 | Q00059 | |
| QKDTSKNAWTDTKVK | 511 | O00444 | |
| KNAWTDTKVKKNSDA | 516 | O00444 | |
| SQTLKRDKEKKNNPW | 416 | Q14141 | |
| DKIDLNDWKSNTRLK | 636 | Q9HCE7 | |
| KWVNEKKAQEDKLQT | 416 | Q05682 | |
| SLVKDNKWKKTEETQ | 161 | Q7L1S5 | |
| NKWKKTEETQEKRRS | 166 | Q7L1S5 | |
| SKVTEQEWREKAKKD | 121 | P09497 | |
| KVKESNIWKKLSFEE | 676 | Q96JI7 | |
| KDAWASDQKVKALKI | 196 | Q7Z3J2 | |
| QWDREFKKENTKEEK | 186 | Q9UIV8 | |
| QEEKWCEKAVKSLVK | 36 | Q15796 | |
| QEEKWCEKAVKSLVK | 26 | P84022 | |
| IKKWKVSTEAELRQK | 116 | Q15431 | |
| LKNKFDVTWKQAKDI | 606 | P10266 | |
| LKNKFDVTWKQAKDI | 606 | P63133 | |
| LKNKFDVTWKQAKDI | 606 | Q9UQG0 | |
| KGDWKQKFRKEDTQL | 186 | O75830 | |
| KAANRWKEETKKLTE | 586 | Q96NL6 | |
| SWTNASKKQREKLLE | 476 | O00507 | |
| TLWDANSEVEKKQKS | 266 | Q7Z5U6 | |
| WKANTTSNKEKEEIL | 146 | Q6PF05 | |
| EKKAQKKSRQAWLTA | 466 | Q6ZUG5 | |
| AIKRADWKKTVETQK | 161 | P19474 | |
| AKTVQEKAAKIKEWV | 121 | Q9ULM0 | |
| KTDWEVAIKSINKKN | 31 | Q8IYT8 | |
| DKVEGQKQKLEAWKN | 1131 | Q6R2W3 | |
| EDKWRVAKKTKDVTV | 26 | Q96DR4 | |
| ISASDKKKKQEWIQA | 286 | Q9UH65 | |
| EVKNATQWKDKIKSQ | 181 | Q9C037 | |
| TKEDGEKETWKVSNK | 671 | Q9NUA8 | |
| QEKKEEKEKSTALTW | 616 | Q9UNY4 | |
| ENKANSRLAWKEVKK | 706 | Q9Y3Q0 | |
| RKQWKNKKRESAAVT | 521 | O15146 | |
| WKIEKNKISISDSIK | 1026 | Q86UW6 | |
| RKWEDDLKKNSSVNE | 531 | O14974 | |
| KRKWTETQDSSQKKS | 126 | Q9HAN9 |